Retatrutide's Potential FDA Approval Timeline for 2026 Discussed | Retatrutide News

Retatrutide, a weight loss drug by Eli Lilly, is potentially set for FDA approval in 2026. This development highlights the ongoing progress in GLP-1 ago...
Market News · October 23, 2026